![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1983/nejm_1983.309.issue-15/nejm198310133091503/20130822/images/img_medium/nejm198310133091503_t1.jpeg)
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg?width=800&height=600&carousel=1)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![The significance of elevated tumor markers among patients with interstitial lung diseases | Scientific Reports The significance of elevated tumor markers among patients with interstitial lung diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-20683-w/MediaObjects/41598_2022_20683_Fig1_HTML.png)
The significance of elevated tumor markers among patients with interstitial lung diseases | Scientific Reports
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/Articles/692083/fcvm-08-692083-HTML/image_m/fcvm-08-692083-g001.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356519312388-gr1.jpg)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
![Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/7d7a4bac-4449-4be0-82ed-9187e01a5506/tog12704-fig-0002-m.jpg)
Raised CA125 – what we actually know… - Howe - 2021 - The Obstetrician & Gynaecologist - Wiley Online Library
![PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a41774d54ed2429de098b01664d00db2774149da/6-Figure2-1.png)
PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar
![JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis](https://www.mdpi.com/jcm/jcm-08-00607/article_deploy/html/images/jcm-08-00607-g001.png)